Latest stories on GUTS
Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization
GlobeNewswire64 · neutralproduct/pr
Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization
Business Insider64 · neutralproduct/pr
Fractyl Health co-founder Jay Caplan to retire, continue as advisor
The Fly48 · neutralgeneral
Fractyl Health ends Rejuva development, sees cash runway into Q2 2027
The Fly42 · neutralgeneral
Fractyl Health cuts about 45% of workforce to focus on Revita
The Fly34 · bearishgeneral
Fractyl Health Refocuses Strategy Around Revita Program
TipRanks58 · neutralproduct/pr
FRACTYL HEALTH, INC. (GUTS) files 8-K
SEC 8-K42 · neutralgeneral
Canaccord cuts Fractyl Health stock price target on capital needs
Investing.com Analyst Ratings34 · bearishanalyst
Fractyl Health price target lowered to $39 from $96 at Canaccord
The Fly28 · bearishanalyst
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Fractyl Health, Inc. to Contact Law Firm
PR Newswire34 · bearishgeneral
Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire34 · bearishgeneral
Fractyl Health price target lowered to $5 from $48 at Craig-Hallum
The Fly22 · bearishanalyst
Fractyl Health Stock (GUTS) Sinks Over 58% on Trial Results and a Lawsuit
TipRanks22 · bearishgeneral
FRACTYL HEALTH, INC. (GUTS) files 8-K
SEC 8-K50 · neutralgeneral